The European LeukemiaNet: achievements and perspectives

Autor: Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, Jane Apperley, Michele Baccarani, Tiziano Barbui, Giovanni Barosi, Renato Bassan, Marie C. Béné, Ute Berger, Thomas Büchner, Alan Burnett, Nicolas C.P. Cross, Theo J.M. de Witte, Hartmut Döhner, Hervé Dombret, Hermann Einsele, Georg Engelich, Robin Foà, Christa Fonatsch, Nicola Gökbuget, Elaine Gluckman, Alois Gratwohl, Francois Guilhot, Claudia Haferlach, Thorsten Haferlach, Michael Hallek, Jörg Hasford, Andreas Hochhaus, Dieter Hoelzer, Jean-Jaques Kiladjian, Boris Labar, Per Ljungman, Ulrich Mansmann, Dietger Niederwieser, Gert Ossenkoppele, José M. Ribera, Harald Rieder, Hubert Serve, Petra Schrotz-King, Miguel A. Sanz, Susanne Saußele

Publikováno v: Haematologica, Vol 96, Iss 1 (2011)

The only way to cure leukemia is by cooperative research. To optimize research, the European LeukemiaNet integrates 105 national leukemia trial groups and networks, 105 interdisciplinary partner groups and about 1,000 leukemia specialists from 175 in

Externí odkaz: https://doaj.org/article/8876d1f1a9dc493dacbb68ef3f24a52e

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Autor: Michael Pfreundschuh, Matthias Edinger, Martin Wilhelm, Christiane Falge, Jörg Th. Fischer, Bernd Hertenstein, Markus Pfirrmann, Donald Bunjes, J Novotny, Susanne Schnittger, Michael Schatz, Artur Wehmeier, Andreas Hochhaus, Herbert G. Sayer, Ingo G.H. Schmidt-Wolf, Christoph Nerl, Claudia Haferlach, Susanne Saußele, Matthias Fabian, Martin C. Müller, Arnold Ganser, Joerg Hasford, Dieter K. Hossfeld, Anthony D. Ho, Hans-Jochem Kolb, Peter Staib, Herrmann Heimpel, Hartmut Döhner, Axel A. Fauser, Andreas Reiter, Michael Schenk, Renate Arnold, Gabriela M. Baerlocher, Rainer Schwerdtfeger, Carlo Aul, Rüdiger Hehlmann, Rolf Kuse, Thomas Kindler, Axel R. Zander, Gerald Wulf, Norbert Schmitz, Otto Prümmer, Karsten Spiekermann, Maria-Elisabeth Goebeler, Ute Berger, Anne Rosselet, Nicolaus Kröger, Dietrich W. Beelen, Alois Gratwohl, Günter Schlimok, Jiří Mayer, Andrzej Hellmann, Herrad Baurmann, Matthias Bormann, Hans Walter Lindemann, Christof Scheid, E. Schäfer, Guntram Büsche

Publikováno v: Gratwohl, A; Pfirrmann, M; Zander, A; Kröger, N; Beelen, D; Novotny, J; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Sayer, H G; Falge, C; Bunjes, D; Döhner, H; Ganser, A; Schmidt-Wolf, I; Schwerdtfeger, R; Baurmann, H; Kuse, R; Schmitz, N; ... (2016). Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia, 30(3), pp. 562-569. Nature Publishing Group 10.1038/leu.2015.281
Leukemia, vol. 30, no. 3, pp. 562-569
Leukemia

Tyrosine kinase inhibitors represent today's treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as salvage therapy. This prospective randomized CML-study IIIA recruited 669 pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343c3126b8797d956f29c42c090048c4
https://doi.org/10.1038/leu.2015.281

Klinische Forschung im Kompetenznetz 'Akute und chronische Leukämien'

Autor: Karl Überla, Dieter Hoelzer, Hartmut Döhner, Gerhard Ehninger, Thomas Büchner, Rüdiger Hehlmann, Carlo Aul, Ute Berger, Nicola Gökbuget, Arnold Ganser, Susanne Saussele

Publikováno v: Medizinische Klinik. 101:414-420

D Background: Leukemias are a challenge and a cost factor to society because of their frequency in all age groups. They also serve as a model for a variety of diseases and possess exemplary relevance for basic research and patient care. Leukemia rese

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ccf3b50b3e8b654118f0412cda67bc0
https://doi.org/10.1007/s00063-006-1056-2

The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2

Autor: Nick Telford, Rüdiger Hehlmann, Andreas Reiter, Brigitte Schlegelberger, Ute Berger, Danny Vanstraelen, Cornelia Rudolph, Hans-Jochem Kolb, Ilona Blau, Shilani Aruliah, John A Yin, Christoph Walz, Peter C Taylor, Helen F Barker, Claudia Schoch, Aisling O'Driscoll, Ann E. Watmore, Andreas Hochhaus, Nicholas C.P. Cross, Andrew Chase, Fabio Benedetti

Publikováno v: Cancer Research. 65:2662-2667

We have identified a t(8;9)(p21-23;p23-24) in seven male patients (mean age 50, range 32-74) with diverse hematologic malignancies and clinical outcomes: atypical chronic myeloid leukemia/chronic eosinophilic leukemia (n = 5), secondary acute myeloid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76819641b64e9ffc13a97566b75abf2
https://doi.org/10.1158/0008-5472.can-04-4263

Das Kompetenznetzwerk 'Akute und chronische Leukämien'

Autor: Ute Berger, Hartmut Döhner, C. Aul, Karl Überla, A. Ganser, Ruediger Hehlmann, G. Ehninger, Thomas Büchner, Dieter Hoelzer, N. Gökbuget

Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 129:2660-2665

Leukemias are a challenge and a cost factor to society because of their frequency in all age groups. They also serve as a model for a variety of diseases and possess exemplary relevance for basic research and patient care. Leukemia research and thera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63ac229172389786411f0381b6e2d263
https://doi.org/10.1055/s-2004-836093